Human Papillomavirus Infection in Women in Four Regions of Senegal

被引:24
作者
Mbaye, El Hadji Seydou [1 ,2 ,3 ]
Gheit, Tarik [1 ]
Dem, Ahmadou [3 ]
McKay-Chopin, Sandrine [1 ]
Toure-Kane, Ndeye Coumba [2 ]
Mboup, Souleymane [2 ]
Tommasino, Massimo [1 ]
Sylla, Bakary S. [1 ]
Boye, Cheikh Saad Bouh [2 ]
机构
[1] WHO, IARC, Lyon, France
[2] Aristide Le Dantec Hosp, Lab Bacteriol & Virol, Dakar, Senegal
[3] Aristide Le Dantec Hosp, Inst Canc, Dakar, Senegal
关键词
papillomavirus; cervical cancer; Senegal; SQUAMOUS INTRAEPITHELIAL LESIONS; INVASIVE CERVICAL-CANCER; HIGH-RISK; HPV INFECTION; PREVALENCE; EPIDEMIOLOGY; DETERMINANTS; VACCINES; AFRICA; SAFETY;
D O I
10.1002/jmv.23719
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cervical cancer is the most frequent cancer among women in Senegal. However, there are few data concerning the human papillomavirus (HPV) types inducing neoplasia and cervical cancers and their prevalence in the general population of Senegal. The aim of this study is to determine the prevalence of HPV infection in Senegalese women aged 18 years and older in Dakar Region and three other regions. Cervical samples were collected from 498 women aged 18-80 years (mean, 42.1 years) in Dakar Region. Also, 438 samples were collected from three other regions: Thies, Saint-Louis, and Louga. The samples were screened for 21 HPV genotypes using an HPV type-specific E7 PCR bead-based multiplex genotyping assay (TS-MPG). The prevalence of high risk (HR)-HPV in Dakar Region was 17.4%. HPV 52 (3.2%) was the most prevalent HPV type, followed by HPV 31 (3.0%) and HPV 16, 45, and 53 (all 2.8%). In the Thies, Saint-Louis, and Louga Regions, the prevalence of HR-HPV was 23.2%, 13.1%, and 19.4%, respectively. The study revealed the specificity of HPV prevalence in Dakar Region and other regions of Senegal. The observed patterns show some differences compared with other regions of the world. These findings raise the possibility that, in addition to HPV 16 and HPV 18, other HPV types should be considered for a vaccination program in Senegal. However, additional studies to determine the HPV type distribution in cervical cancer specimens in Senegal are required to further corroborate this hypothesis. J. Med. Virol. 86:248-256, 2014. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:248 / 256
页数:9
相关论文
共 41 条
[1]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P118
[2]  
[Anonymous], IARC MON EV CARC RIS
[3]  
[Anonymous], 2010, HUM PAP REL CANC
[4]   Worldwide burden of cervical cancer in 2008 [J].
Arbyn, M. ;
Castellsague, X. ;
de Sanjose, S. ;
Bruni, L. ;
Saraiya, M. ;
Bray, F. ;
Ferlay, J. .
ANNALS OF ONCOLOGY, 2011, 22 (12) :2675-2686
[5]   Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer [J].
Arbyn, Marc ;
Ronco, Guglielmo ;
Anttila, Ahti ;
Meijer, Chris J. L. M. ;
Poljak, Mario ;
Ogilvie, Gina ;
Koliopoulos, George ;
Naucler, Pontus ;
Sankaranarayanan, Rengaswamy ;
Peto, Julian .
VACCINE, 2012, 30 :F88-F99
[6]   Risk factors of invasive cervical cancer in Mali [J].
Bayo, S ;
Bosch, FX ;
de Sanjosé, S ;
Muñoz, N ;
Combita, AL ;
Coursaget, P ;
Diaz, M ;
Dolo, A ;
van den Brule, AJC ;
Meijer, CJM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (01) :202-209
[7]   A review of human carcinogens-Part B: biological agents [J].
Bouvard, Veronique ;
Baan, Robert ;
Straif, Kurt ;
Grosse, Yann ;
Secretan, Beatrice ;
El Ghissassi, Fatiha ;
Benbrahim-Tallaa, Lamia ;
Guha, Neela ;
Freeman, Crystal ;
Galichet, Laurent ;
Cogliano, Vincent .
LANCET ONCOLOGY, 2009, 10 (04) :321-322
[8]   Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings [J].
Bruni, Laia ;
Diaz, Mireia ;
Castellsague, Xavier ;
Ferrer, Elena ;
Bosch, F. Xavier ;
de Sanjose, Silvia .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (12) :1789-1799
[9]   Determinants of cervical human papillomavirus infection: Differences between high- and low-oncogenic risk types [J].
Chan, PKS ;
Chang, AR ;
Cheung, JLK ;
Chan, DPC ;
Xu, LY ;
Tang, NLS ;
Cheng, AF .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (01) :28-35
[10]  
Clifford G, 2013, PAPILLOMAVIRUS REP, V16, P322, DOI [10.1179/095741905x49089, DOI 10.1179/095741905X49089]